Colloidal silicic acid for the treatment of psoriatic skin lesions, arthropathy and onychopathy. A pilot study

Journal of International Medical Research

Volumn 25, Issue 4, 1997, Pages 206-209

  Lassus, A ^a  

^a Helsinki Research Center   (Finland)

Author keywords

Psoriasis; Psoriatic arthropathy; Psoriatic onychopathy; Silicic acid

Indexed keywords

ANTIPSORIASIS AGENT; SILICIC ACID; SILICOL; UNCLASSIFIED DRUG;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELBOW; FEMALE; HUMAN; KNEE; MALE; NAIL DISEASE; ORAL DRUG ADMINISTRATION; PSORIASIS; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION;

EID: 0030822074     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059702500406     Document Type: Article

References (4)

1. Fregert S: Studies on silicon in tissues with special reference to skin. J Invest Dermatol 1958; 31: 95-96.
2. Fregert S: Studies on silicon in tissues with special reference to skin. Acta Derm Venereol Suppl (Stockh) 1959; 42: 1-92.
3. Lassus A: Colloidal silicic acid for oral and topical treatment of aged skin, fragile hair and brittle nails in females. J Int Med Res 1993; 21: 209-215.
4. Berglund K, Johansson B-G, Nived O, et al: Inflammatory parameters in rheumatoid arthritis during and after administration of an antimitotic agent (podophyllom lignan derivatives). Scand J Rheum- atol 1975; 7: 61-63.